Evidence map›Paper›PMID 37761760›Full record

ArticleHealthcare (Basel, Switzerland)2023

A Nutritional Supplement as Adjuvant of Gabapentinoids for Adults with Neuropathic Pain following Spinal Cord Injury and Stroke: Preliminary Results.

William Raffaeli, Giorgio Felzani, Michael Tenti, Luca Greco, Maria Pia D'Eramo, Stefania Proietti, Giovanni Morone

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

William RaffaeliISAL Foundation, Institute for Research on Pain, 47921 Rimini, Italy.ORCID 0000-0003-0240-8993
Giorgio FelzaniSan Raffaele Institute of Sulmona, 67039 Sulmona, Italy.ORCID 0000-0002-0630-4625
Michael TentiISAL Foundation, Institute for Research on Pain, 47921 Rimini, Italy.ORCID 0000-0002-4654-018X
Luca GrecoSan Raffaele Institute of Sulmona, 67039 Sulmona, Italy.ORCID 0009-0004-9380-9729
Maria Pia D'EramoSan Raffaele Institute of Sulmona, 67039 Sulmona, Italy.
Stefania ProiettiUnit of Clinical and Molecular Epidemiology, San Raffaele University, 00166 Rome, Italy.ORCID 0000-0002-9844-1482
Giovanni MoroneSan Raffaele Institute of Sulmona, 67039 Sulmona, Italy.ORCID 0000-0003-3602-4197
Fondazione ISAL · ITSan Raffaele University of Rome · ITUniversity of L'Aquila · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gabapentinoids are first choice drugs for central neuropathic pain (CNP) despite limited evidence of efficacy and side effects affecting therapy outcomes. Nutraceuticals could improve their efficacy and tolerability. Our aim is to investigate the effect of NACVAN

Indexed as

adjuvantgabapentinoidsneuropathic painpregabalinspinal cord injurystrokesupplements

Identifiers

PMID37761760
PMCPMC10531277
OpenAlexW4386835690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.